Cardiovascular adverse events
Silodosin showed no clear difference in cardiovascular adverse events compared with alfuzosin (low certainty).
1 finding from 1 review
Cardiovascular adverse events
It is very uncertain whether silodosin changes cardiovascular adverse events compared with placebo (very low certainty).
1 finding from 1 review
Cardiovascular adverse events
Silodosin showed no clear difference in cardiovascular adverse events compared with tamsulosin (low certainty).
1 finding from 1 review
Intervention not reported
Adverse Events ‐ not reported · participants with lumbar spinal stenosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular adverse events
1 finding from 1 review
Cardiovascular adverse events
1 finding from 1 review
Intervention not reported
Withdrawals ‐ adverse events Acute and chronic conditions combined · adults with strains or sprains (acute) or osteoarthritis or low back pain (chronic)
1 finding from 1 review
Intervention not reported
Adverse events ‐ any adverse events Acute and chronic conditions combined · adults with strains or sprains (acute) or osteoarthritis or low back pain (chronic)
1 finding from 1 review
Adverse events at study endpoint · preventing mental disorders
2 findings from 1 review
Adverse events at study endpoint · preventing mental disorders
2 findings from 1 review
Intervention not reported
Adverse events ‐ local adverse events Acute and chronic conditions combined · adults with strains or sprains (acute) or osteoarthritis or low back pain (chronic)
1 finding from 1 review
Withdrawals due to adverse events · participants with normal or abnormal lipid profiles
It is very uncertain whether all doses of cerivastatin changes withdrawals due to adverse events compared with placebo (very low certainty).
1 finding from 1 review
Intervention not reported
Other adverse events Non‐mortality · adult survivors of critical illness
1 finding from 1 review
Adverse events: morbidity related to the shunt placement that has not led to shunt revision · participants with hydrocephalus
1 finding from 1 review
Adverse events (during intervention) · children/adolescents with post‐traumatic stress and related depressive/anxiety symptoms
1 finding from 1 review
Number of participants experiencing muscle‐related adverse events: e.g. soreness, discomfort, cramps, pain · men with urinary incontinence following prostate surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants experiencing muscle‐related adverse events: e.g. soreness, discomfort, cramps, pain · men with urinary incontinence following prostate surgery
It is very uncertain whether combinations of conservative treatments changes number of participants experiencing muscle‐related adverse events:… compared with no treatment, sham treatment or verbal/written instruction (very low certainty).
1 finding from 1 review
Number of participants experiencing muscle‐related adverse events: e.g. soreness, discomfort, cramps, pain · men with urinary incontinence following prostate surgery
1 finding from 1 review
Intervention not reported
Adverse events: superficial infection · adults with open long bone fractures; study in the review included only Gustilo II open tibia fractures
It is very uncertain whether the intervention changes adverse events: superficial infection (very low certainty).
1 finding from 1 review
Adverse events (during intervention)Â · children/adolescents with post‐traumatic stress and related depressive/anxiety symptoms
1 finding from 1 review